On the recordJuly 30, 2020
Should a patient be denied access to a potentially life-saving drug like Remdesivir because a hospital was unable to comply with the sudden change in HHS reporting requirements?
Source
congress.govEditor's note · Context
Waters questions the fairness of HHS reporting changes affecting drug access.
Share
More from Maxine Waters
Dec 1, 2025
Mr. Speaker, I thank my friend and colleague, Ranking Member Green, for his good work on this bill. H.R. 3716 will ensure that if we have another banking emergency, as we did 2 years ago with several regional banks, and regulators respond…
Jul 21, 2025
I support Mr. Himes' bill, which will shed light on how much small- and medium-sized companies are paying for their underwriting fees to go public. I hope it will finally put pressure on the SEC to address this important issue for smaller…
Jul 21, 2025
Compared to investing in publicly traded securities, private securities contain lots of risks. They are less liquid, harder to value, and are more volatile than their public counterparts. It is, therefore, essential that anyone investing…
Jul 21, 2025
I rise in support of H.R. 2384, the Financial Technology Protection Act sponsored by Representative Nunn and Representative Himes. This bill seeks to establish the Independent Financial Technology Working Group to Combat Terrorism and…
Other voices in this conversation
